Preimplantation genetic testing practices in the Nordic countries
- 1 June 2020
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 99 (6), 707-715
- https://doi.org/10.1111/aogs.13821
Abstract
Introduction Preimplantation genetic testing (PGT) is growing in importance and volume internationally. International societies such as the European Society for Human Reproduction and Embryology compile international results and these data are published in scientific journals. We present the first compilation of practices, quality measuress and outcome data from Nordic clinics performing PGT. Material and methods We conducted a structured online survey of PGT practices in the Nordic countries to compare clinical and laboratory techniques, outcomes and quality measures applied in Nordic clinics. The survey was designed by the authors and answered by the authors and members of the study group. The outcome data represents results from 2018. Results and details were clarified through iteration with responding clinics while maintaining anonymity. Response rate in the study was 80%, with 8 of 10 clinics performing PGT responding. Results Most of the PGT cycles in the Nordic countries are funded through the public healthcare system with University Hospitals performing the majority of treatments, 716/848, or 84.4%, of oocyte retrievals in this dataset. The genetic analyses are in five cases performed by the affiliated local genetic laboratory, and the remaining three consult with large international private enterprise laboratories. Genetic counseling is widely used. Results in the Nordic clinics compare well with international data. Systematic quality control procedures are in place and the larger clinics and laboratories utilize ISO certification or accreditation in the quality management. Automatic witnessing with detailed electronic documentation of laboratory processes is not utilized in the responding clinics, although a majority uses manual witnessing procedures in the laboratory. The outcome after PGT in terms of clinical pregnancy per transfer is around 40% per embryo transfer and compares well with international data. Conclusions Preimplantation genetic testing is organized in rather few clinics in the Nordic countries and most of them use local laboratories for genetic analyses of the biopsies. Laboratory procedures are largely in accordance with international guidelines and the outcome after PGT in terms of clinical pregnancy per transfer is comparable to results in international reports.Keywords
This publication has 27 references indexed in Scilit:
- The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screeningFertility and Sterility, 2014
- Preimplantation genetic diagnosis with HLA matching – a way to save a childActa Obstetricia et Gynecologica Scandinavica, 2012
- Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection studyFertility and Sterility, 2012
- ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS)Human Reproduction, 2010
- ESHRE PGD consortium best practice guidelines for amplification-based PGDHuman Reproduction, 2010
- ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGDHuman Reproduction, 2010
- ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screeningHuman Reproduction, 2010
- Guidelines for good practice in PGD: programme requirements and laboratory quality assuranceReproductive BioMedicine Online, 2008
- Preimplantation genetic diagnosis for Huntington's disease with exclusion testingEuropean Journal of Human Genetics, 2002
- Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplificationNature, 1990